文献速递炎症性肠病

克罗恩病及肠道炎症严重程度的血液来源DNA甲基化特征

Blood-Derived DNA Methylation Signatures of Crohn's Disease and Severity of Intestinal Inflammation.
PubMed 文献 · Gastroenterology · 2019-02-16

研究纳入164例1-17岁初诊克罗恩病患儿和74例对照,随访5年,分析约85万个位点的DNA甲基化。初诊时鉴定出1189个差异甲基化CpG位点,其甲基化变化与血浆C反应蛋白水平相关;治疗后这些改变趋于对照模式,提示血液甲基化改变是炎症的结果而非病因。

要点

  • 初诊克罗恩病患儿与对照间有1189个CpG位点差异甲基化,且与血浆C反应蛋白水平相关。
  • 治疗后初诊时的甲基化改变更接近对照,与是否进展为B2型无关。
  • 鉴定出3个CpG位点的甲基化改变可能参与克罗恩病发生,多数改变随炎症治疗消失。

核心结论

  • 血液样本中克罗恩病相关DNA甲基化模式伴随急性炎症出现,治疗后变得类似无肠道炎症者的模式。
  • 这些甲基化模式是疾病炎症特征的结果,较少可能参与疾病发生或进展。

研究设计与样本

  • 研究纳入164例参与北美研究的1-17岁克罗恩病患儿(B1或B2型),随访5年;对照为无肠道炎症或症状者74例。
  • 在初诊时及1-3年后采集血样,分析约85万个位点的DNA甲基化模式。
  • 采用遗传关联和孟德尔随机化概念,识别可能参与克罗恩病发生或由其导致的DNA甲基化改变。

主要发现

  • 初诊克罗恩病患者与对照间鉴定出1189个差异甲基化的5'-胞嘧啶-磷酸-鸟苷-3'(CpG)位点。
  • 这些位点的甲基化变化与血浆C反应蛋白水平相关。
  • 比较初诊时与随访期DNA甲基化谱显示,治疗期间初诊时的甲基化改变更接近对照模式,与是否进展为B2型无关。
  • 鉴定出3个CpG位点的甲基化改变可能参与克罗恩病发生。
  • 多数与克罗恩病相关的CpG甲基化改变随炎症治疗消失,可能是克罗恩病的结果。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Crohn's disease is a relapsing and remitting inflammatory disorder with a variable clinical course. Although most patients present with an inflammatory phenotype (B1), approximately 20% of patients rapidly progress to complicated disease, which includes stricturing (B2), within 5 years. We analyzed DNA methylation patterns in blood samples of pediatric patients with Crohn's disease at diagnosis and later time points to identify changes that associate with and might contribute to disease development and progression. METHODS: We obtained blood samples from 164 pediatric patients (1-17 years old) with Crohn's disease (B1 or B2) who participated in a North American study and were followed for 5 years. Participants without intestinal inflammation or symptoms served as controls (n = 74). DNA methylation patterns were analyzed in samples collected at time of diagnosis and 1-3 years later at approximately 850,000 sites. We used genetic association and the concept of Mendelian randomization to identify changes in DNA methylation patterns that might contribute to the development of or result from Crohn's disease. RESULTS: We identified 1189 5'-cytosine-phosphate-guanosine-3' (CpG) sites that were differentially methylated between patients with Crohn's disease (at diagnosis) and controls. Methylation changes at these sites correlated with plasma levels of C-reactive protein. A comparison of methylation profiles of DNA collected at diagnosis of Crohn's disease vs during the follow-up period showed that, during treatment, alterations identified in methylation profiles at the time of diagnosis of Crohn's disease more closely resembled patterns observed in controls, irrespective of disease progression to B2. We identified methylation changes at 3 CpG sites that might contribute to the development of Crohn's disease. Most CpG methylation changes associated with Crohn's disease disappeared with treatment of inflammation and might be a result of Crohn's disease. CONCLUSIONS: Methylation patterns observed in blood samples from patients with Crohn's disease accompany acute inflammation; with treatment, these change to resemble methylation patterns observed in patients without intestinal inflammation. These findings indicate that Crohn's disease-associated patterns of DNA methylation observed in blood samples are a result of the inflammatory features of the disease and are less likely to contribute to disease development or progression.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Somineni HK, Venkateswaran S, Kilaru V, et al. Blood-Derived DNA Methylation Signatures of Crohn's Disease and Severity of Intestinal Inflammation. Gastroenterology. 2019. PMID: 30779925. doi:10.1053/j.gastro.2019.01.270

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。